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Introduction  
 
Cardiovascular disease (CVD) is the leading cause of morbidity and 
mortality in the industrialized countries. Improvements in CVD risk factor 
profiles have led to significant reductions in death from CVD over the past 
50 years, but recent data suggest that the increasing prevalence of obesity 
may have slowed this rate of decline.  
 
The Abdominal Adipose Tissue Compartment  
 
Several metabolic studies demonstrated that central type of obesity pose a 
greater risk for developing obesity-related disorders than obesity defined by 
BMI alone. In particular, the visceral adipose tissue (VAT) compartment 
seems to act as a unique pathogenic fat depot. Visceral adipose tissue has 
been termed an endocrine organ, in part because it secretes adipocytokines 
and other vasoactive substances that can influence the risk of developing 
metabolic disorders. Furthermore, it became clear that chronic low-grade 
inflammation is encountered in individuals with an excess of visceral fat. 
Thus, in terms of its proinflammatory and metabolic features, visceral 
adiposity is an emergent powerful but modifiable risk factor for CVD. 
Therefore, the precise and reproducible quantification of abdominal fat 
depots is important in order to further characterize the role of adipose tissue 
in the development of cardiovascular disorders. Current imaging studies 
evaluating abdominal fat depots are limited to small, referral-based samples 
often enriched for adiposity-related traits. Furthermore, no data is available 
in a community-based sample of women and men free of CVD across the 
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spectrum of BMI whether the volume of subcutaneous adipose tissue (SAT) 
and VAT are associated with metabolic risk factors and markers of 
inflammation cross-sectionally.  
 
The Pericoronary Adipose Tissue Compartment  
 
Epicardial adipose tissue (EAT) covers 70-100% of the cardiac 
circumference as a layer of adipose tissue between the myocardium and the 
visceral pericardium. It has been suggested that adipocytokines produced by 
fat surrounding the coronary arteries might amplify vascular inflammation 
and generate a pro-atherogenic milieu. The portions of EAT which directly 
surround the coronary arteries is termed the pericoronary adipose tissue 
(PCAT) compartment.  
The precise and reproducible quantification of this rather small fat 
compartment is crucial for the understanding of its role in the 
pathophysiology of coronary artery disease. The most commonly used 
techniques for PCAT quantification in CT datasets are based on thickness 
and area measurements on a limited number of axial image slices. These 2-
dimensional quantification techniques do not reflect the inhomogeneous 
distribution of PCAT along the atrioventricular and interventricular grooves.  
 
Aims 
 
Planimetric and volumetric adipose tissue quantification methods 
We sought to assess the intra- and inter-observer reproducibility of MDCT 
based volumetric quantification of subcutaneous and visceral abdominal 
adipose tissue. Furthermore, our aim was to investigate the differences 
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between the relative amounts of visceral and subcutaneous abdominal tissue 
quantity as assessed by volumetric and planimetric methods.  
 
Abdominal adipose tissue volumes and metabolic risk factors  
We aimed to assess whether the volume of SAT and VAT are associated 
with metabolic risk factors in a community-based sample free of CVD. 
Furthermore, we sought to determine whether sophisticated volumetric 
imaging methods of SAT and VAT provide information about metabolic risk 
other than that offered by classic anthropometric measures such as BMI and 
waist length (WL). 
 
Abdominal adipose tissue volumes and markers of inflammation and 
oxidative stress 
We aimed to investigate the association of abdominal fat compartment 
volumes with a panel of systemic inflammatory markers. Furthermore, we 
sought to assess whether volumetric measurements of SAT and VAT 
explained additional interindividual variability in biomarker concentrations 
above that accounted for by the simple clinical anthropometric measures of 
obesity (BMI and WL).  
 
Novel volumetric pericoronary adipose tissue quantification 
We aimed to assess the feasibility and reproducibility of a novel threshold-
based method of PCAT volume quantification using cardiac CT, furthermore 
to determine the relationship of PCAT volume with the presence of coronary 
atherosclerotic plaque on patient, vessel and subsegment basis.  
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Methods 
 
Study population  
Participants for abdominal adipose tissue assessment were drawn from the 
Framingham Heart Study Multidetector Computed Tomography Study, a 
population-based substudy of the community-based Framingham Heart 
Study Offspring and Third-Generation Study cohorts. Between June 2002 
and April 2005, 3529 participants (2111 third generation, 1418 offspring 
participants) underwent chest and abdominal MDCT scan. Men had to be 
≥35 years of age; women had to be ≥40 years of age and not pregnant (1,2).  
The biomarkers and inflammatory substances were assessed in the offspring 
participants with technically interpretable CT scans (n=1377), attendance at 
the seventh examination cycle (1998-2001; n=1355), complete covariate 
information (n=1253), and measurement of at least one inflammatory 
marker, resulting in a total sample size of 1250 participants.  
Participants for pericoronary adipose tissue assessment were drawn from the 
ROMICAT (Rule Out Myocardial Infarction using Computer Assisted 
Tomography) trial. From the 368 ROMICAT patients, we included 51 
patients in this age- and gender-matched 1:1:1 case-control design. Patients 
were stratified into 3 groups based on presence of coronary atherosclerosis 
and hs-CRP levels. Group 1 included patients with presence of coronary 
plaque and hs-CRP >2.0 mg/L; intermediate group (Group 2) included 
patients with no plaque and hs-CRP >2.0 mg/L, Group 3 included patients 
with no plaque and hs-CRP <1.0 mg/L.  
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Abdominal Adipose Tissue Assessment  
All subjects underwent CT scanning using an eight-slice MDCT 
(LightSpeed Ultra, General Electric, Milwaukee, WI, USA). Twenty-five 
contiguous 5 mm thick slices were acquired covering 125 mm above the 
level of S1. The raw data were reconstructed using a 55 cm field of view. 
The effective radiation exposure was 2.7 mSv (1). 
We measured the subcutaneous and visceral adipose tissue areas (SAA and 
VAA) and volumes (SAV and VAV) as well as the waistline (WL) and 
sagital diameter (SD) using a dedicated offline workstation (Aquarius 3D 
Workstation, TeraRecon Inc., San Mateo, CA, USA). The SAA and VAA as 
well the WL and SD were measured using a single slice (5mm thickness) at 
the umbilical level, whereas the SAV and VAV were assessed using the 
whole imaging volume (1).  
The reproducibility study sample represents a random subset of 100 subjects 
(age range: 37 – 83 years; 49% female). Two observers performed an 
independent analysis of all datasets in random order to assess for inter-
observer variability. One reader repeated the analysis one week later to 
assess for intra-observer variability (1). 
Risk factors and biomarkers were measured at the regular Framingham 
Study examinations. 
 
Pericoronary Adipose Tissue Assessment  
Contrast-enhanced gated CT imaging was performed using a standard 
coronary artery 64-slice MDCT (Sensation 64, Siemens Medical Solutions, 
Forchheim, Germany) imaging protocol.  
We started the PCAT quantification at the ostium of the left main (LM)/left 
anterior descending coronary artery (LAD), left circumflex artery (LCx), and 
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right coronary artery (RCA). The method of threshold-based volumetric 
PCAT assessment is based on a modified application of software for 
volumetric assessment of coronary atherosclerotic plaques (Vitrea 2, Version 
3.9.0.1, Vital Images Inc, Plymouth, MN and SUREPlaque, Toshiba 
Medical Systems, Tustin, CA). We recorded PCAT volumes in 5 mm 
increments, and summed PCAT along the measured vessel lengths. Two 
independent readers who were blinded to the coronary plaque and hs-CRP 
results performed the PCAT measurements. Observer 1 performed 
measurements around the proximal 40 mm of the coronaries in all 51 
patients once. For inter-observer and intra-observer reproducibility, observer 
2 performed the measurements in 20 randomly selected patients, and 
Observer 1 repeated this process in the same 20 patients 1 month later. A 
total of 153 vessels and 1224 coronary artery subsegments were evaluated 
across the three patient groups. 
 
Results 
The reproducibility study 
The mean SAV was 2929.8±1260.0 cm3 (range of 501.0 - 6695.0) and the 
mean VAV was 2031.6±1013.7 cm3 (range of 288.0 - 4731.0). The mean 
SAA was 543.5±252.4 cm2 and the mean VAA was 325.9 ± 162.3 cm2. The 
mean WL was 100.0±12.3 cm (range of 74.9 - 131.3) and the mean SD was 
24.2±4.0 cm (range of 15.9 - 35.9). 
The intra-observer reproducibility was excellent for VAV and SAV 
(ICC=0.99). The mean absolute intra-observer differences were small and 
non-significant for both measurements (SAV: -0.6±6.1 cm3, p=0.29; VAV: 
0.7±6.0 cm3; p=0.26).  
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The mean absolute difference was 0.1±0.6 cm (p=0.09) for WL 
measurements and -0.01±0.2 cm (p=0.68) for SD measurements. Both WL 
and SD measurements were highly correlated (ICC: 0.99).  
The mean absolute inter-observer differences were extremely small and both 
measurements were highly correlated (SAV: -9.1±12.0 cm3, ICC=0.99, and 
VAV: 9.9±14.8 cm3; ICC=0.99). The relative difference between observers 
was small and non-significant -0.34%±0.52% for SAV and 0.59%±0.93% 
for VAV (p=n.s.). 
The mean WL was 100.0±12.3 cm (range of 74.9-131.3) with a mean 
absolute difference of -0.1±0.8 cm and a mean relative difference of -0.08% 
±0.84% between the two observers (ICC=0.99). The mean SD was 24.2±4.0 
cm (range of 15.9 - 35.9) with a mean absolute difference of -0.2 ±0.4 cm 
and a mean relative difference of -0.73%±1.82% (ICC=0.99). 
The mean SAA/VAA ratio (2.0±1.2; range: 0.5 - 6.7) was significantly 
greater than the mean SAV/VAV ratio (1.7 ± 0.9; range: 0.4 - 5.3); 
(p<0.001) (1). 
 
The abdominal adipose tissue depots and metabolic risk factors 
Overall, 1452 women and 1549 men were available for analysis. The mean 
age was 50 years; approximately one quarter of the sample was 
hypertensive, 5% had diabetes, and approximately one third had metabolic 
syndrome (MetS). Approximately half of the women were postmenopausal. 
The mean SAT volume among the offspring and the third gen participants 
was 3071±1444 cm3 in women and 2603±1187 cm3 in men. The mean VAT 
volume in women was 1306±807 cm3 and in men was 2159±967 cm3.  
SAV was positively correlated with age in women (r=0.13, P<0.001) but not 
men, and VAV was positively correlated with age in both sexes (r=0.36 in 
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women and men, P<0.001). SAV and VAV were highly correlated, with an 
age-adjusted correlation coefficient between SAV and VAV of 0.71 
(P<0.0001) in women and 0.58 (P<0.0001) in men. Both BMI and WL were 
strongly correlated with SAV and VAV after adjustment for age. All risk 
factors were highly correlated with both SAV and VAV, except for serum 
total cholesterol with SAV in men and physical activity index with VAV in 
men. 
In women and men, the association of both SAV and VAV with continuous 
measures of metabolic risk factors was highly significant. For fasting plasma 
glucose, the effect of VAV was stronger than that of SAV (P<0.0001 for 
difference in women, P=0.001 in men). Strong and significant results for log 
triglycerides and HDL cholesterol followed similar patterns.  
Highly significant associations with SAV and VAV also were noted for 
dichotomous risk factor variables. Among women and men, both SAV and 
VAV were associated with an increased odds of hypertension. In women, the 
odds ratio of hypertension per 1-SD increase in VAV (odds ratio, 2.1) was 
stronger than that for SAV (odds ratio, 1.7; P=0.001 for difference between 
SAV and VAV); similar differences were noted for men. Similar highly 
significant differences also were noted for impaired fasting glucose, 
diabetes, and MetS.  
The magnitude of association between VAV and all risk factors examined 
was consistently greater for women than for men. Weaker sex differences 
were observed for SAV (2). 
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Abdominal Adipose Tissue Depots and the Markers of Inflammation 
and Oxidative Stress 
The mean age of the 1250 individuals (52% women) was 60±9 years. Mean 
SAV was 3023±1329 cm3, and mean VAV was 2126±1112 cm3. SAV and 
VAV were positively and similarly correlated with most circulating 
inflammatory biomarkers. CD40 ligand, lipoprotein-associated 
phospholipase A2 (Lp-PLA2), osteoprotegerin, and tumor necrosis factor 
(TNF)-α were not correlated with either SAV or VAV. 
In multivariable models, CRP, fibrinogen, intercellular adhesion molecule-1 
(ICAM-1), IL-6, isoprostanes, monocyte chemoattractant-1 (MCP-1), P-
selectin, and TNF receptor-2 remained associated with both SAV and VAV. 
For most markers, the estimated increase in concentrations per 1 SD of SAV 
was comparable to and not statistically significantly different from that of 
VAV, with 2 exceptions. For isoprostanes, the magnitude of the estimated 
association with VAV was almost double that of SAV (p=0.002 for 
difference in effect between SAV versus VAV). Although less striking, we 
also observed differences in the magnitude of the SAV versus VAV 
association with MCP-1 (p=0.04 for SAV versus VAV comparison) (3). 
 
Pericoronary Adipose Tissue Quantification 
The average PCAT volume was 26.98±13.33 cm3 (range: 5.45 – 60.54 cm3). 
The reproducibility of PCAT volume measurement was excellent with intra-
observer and inter-observer ICC >0.94 overall and >0.87 on a per-vessel 
basis. The Bland-Altman analysis of the individual reads by Observer 1 and 
2 for PCAT volume on a per patient basis with good concordance and slight 
systematic bias at greater PCAT volumes. 
In a patient-based analysis, PCAT volume differed significantly across the 
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three groups (p<0.0001), and was greater in patients with coronary plaque 
(Group 1) than no plaque irrespective of hs-CRP levels (Group 2:  high hs-
CRP, p<0.0001; Group 3:  low hs-CRP, p<0.0001). Moreover, in patients 
without plaque, no difference in PCAT volume was seen between patients 
with high and low hs-CRP levels (p=1.0).  The difference in PCAT volumes 
remained significant across the three patient groups after adjustment for 
BMI, hypertension, and hyperlipidemia (p=0.0002). To determine the 
relationship of local adipose tissue volume and coronary plaque distribution, 
a subsegment-based analysis was performed in 5 mm increments to assess 
PCAT quantity adjacent to 1224 vessel subsegments with and without 
plaque. No atherosclerotic plaque was detected in 1005 subsegments while 
219 subsegments contained plaque.  The median fat volume surrounding 5 
mm vessel subsegments with plaque was higher compared to subsegments 
without plaque (p<0.0001).   
 
Conclusions 
We demonstrated an excellent intra- and inter-observer reproducibility of 
MDCT based volumetric quantification of subcutaneous and visceral 
abdominal adipose tissue. We also demonstrated significant differences of 
the relative amounts of visceral and subcutaneous abdominal tissue between 
volumetric and planimetric measurements. Although both SAV and VAV 
correlated with metabolic risk factors, VAV remained more strongly 
associated with an adverse metabolic risk profile even after accounting for 
standard anthropometric indexes. Our findings are consistent with the 
hypothesized role of visceral fat as a unique, pathogenic fat depot. 
Furthermore, we found an association between both SAV and VAV with 
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inflammation and oxidative stress. The data suggest that the contribution of 
visceral fat to inflammation may not be completely accounted for by clinical 
measures of obesity (body mass index and waist circumference).  
Measurement of VAV and SAV may provide a more complete 
understanding of metabolic and cardiovascular risk, and further studies are 
warranted to prospectively assess the impact of VAV and SAV lowering on 
the incidence of MetS and CVD.  
Furthermore, we demonstrated the feasibility and excellent reproducibility of 
a novel threshold-based method for PCAT volume assessment. The local 
amount of PCAT volume was increased in the presence of plaque at the 
patient, vessel, and subsegmental level.  In patients without plaque, PCAT 
volume did not differ based on hs-CRP level, highlighting the potential role 
of local PCAT depots in the process of atherogenesis in addition to systemic 
inflammatory processes. Further studies are needed to validate our findings 
and elucidate the role of local adipocytokines on atherosclerosis. 
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